UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of November 2025
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
GSK publishes provisional dividend dates
GSK announces the following dividend dates for
2026:
These dates are indicative and may be subject to
change.
|
Results
|
Announcement date
|
Ordinary Shares Ex-dividend date
|
American Depositary Shares Ex-dividend date
|
Record date
|
Last date for DRIP elections
|
Payable
|
|
Q1 2026
|
Wednesday
29 April 2026
|
Thursday
14 May 2026
|
Friday
15 May 2026
|
Friday
15 May 2026
|
Thursday
18 June 2026
|
Thursday
9 July 2026
|
|
Q2 2026
|
Wednesday
29 July 2026
|
Thursday
13 August 2026
|
Friday
14 August 2026
|
Friday
14 August 2026
|
Thursday
17 September 2026
|
Thursday
8 October 2026
|
|
Q3 2026
|
Wednesday
28 October 2026
|
Thursday
12 November 2026
|
Friday
13 November 2026
|
Friday
13 November 2026
|
Monday
14 December 2026
|
Thursday
7 January 2027
|
|
Q4 2026
|
Wednesday
3 February 2027
|
Thursday
18 February 2027
|
Friday
19 February 2027
|
Friday
19 February 2027
|
Tuesday
16 March 2027
|
Thursday
8 April 2027
|
V A Whyte
Company Secretary
10
November 2025
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: November
10, 2025
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|